Select a community
HIV
Find out more about the PatientsLikeMe
HIV Community
Home > Community Treatment Reports > Efavirenz-Emtricitabine-Tenofovir Treatment Report
What is Efavirenz-Emtricitabine-Tenofovir?

The combination of efavirenz, emtricitabine, and tenofovir, three widely used antiretroviral drugs, is designed to be taken as one tablet once a day. It may be prescribed for use alone as a complete treatment option or in combination with other antiretroviral medications.

Side Effects

Side effects as an overall problem

Severe
11 13%
Moderate
18 21%
Mild
40 46%
None
18 21%

Most commonly reported side effects

Vivid dreams
52 60%
tiredness
33 38%
Dizziness
32 37%
inconsistent sleep pattern
23 26%
mild sense of balance /dizziness
21 24%
Balance problems
15 17%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Efavirenz-Emtricitabine-Tenofovir. See all 20 dosages ►

  daily 1 daily 1 mg daily 1 tbs. daily 2 tbs. daily 10 g daily 200 mg daily 250 mg daily 300 mg daily 500 mg daily 600 daily 600 mg-200 mg-300 mg daily 600 mg daily 800 mg daily 1100 mg daily 1200 mg daily 2 x 600 mg-200 mg-300 mg daily 3 x 600 mg-200 mg-300 mg daily 30 x 600 mg-200 mg-300 mg daily 100 x 600 mg-200 mg-300 mg daily
  32 Number of Patients: 32 14 Number of Patients: 14 2 Number of Patients: 2 5 Number of Patients: 5 1 Number of Patients: 1 1 Number of Patients: 1 5 Number of Patients: 5 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 244 Number of Patients: 244 27 Number of Patients: 27 1 Number of Patients: 1 5 Number of Patients: 5 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Efavirenz-Emtricitabine-Tenofovir (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe
21 60% Side effects too severe: 60%
Doctor's advice
9 26% Doctor's advice: 26%
Other
7 20% Other: 20%
Personal research
3 9% Personal research: 9%
Did not seem to work
1 3% Did not seem to work: 3%
Expense
1 3% Expense: 3%
Not indicated
1 3% Not indicated: 3%

See all 33 patients who’ve stopped taking Efavirenz-Emtricitabine-Tenofovir

Duration See details about how long patients take this treatment ▼

Currently Taking Efavirenz-Emtricitabine-Tenofovir

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
3
8
28
38
60
50

Stopped Taking Efavirenz-Emtricitabine-Tenofovir

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
10
4
5
7
5
2

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
79 91%
Usually
7 8%
Sometimes
1 1%
Never
0 0%

Burden

Difficulty being on treatment

Very
5 6%
Somewhat
14 16%
A little
24 28%
Not at all
44 51%

Cost

Paid out of pocket

$200+
7 8%
$100-199
4 5%
$50-99
10 11%
$25-49
12 14%
< $25
40 46%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 20, 2009.